129 related articles for article (PubMed ID: 17981666)
1. SDF-1 (CXCL12) in haematopoiesis and leukaemia: impact of DPP IV/CD26.
Hildebrandt M; Schabath R
Front Biosci; 2008 Jan; 13():1774-9. PubMed ID: 17981666
[TBL] [Abstract][Full Text] [Related]
2. CD26/DPP-4 inhibition recruits regenerative stem cells via stromal cell-derived factor-1 and beneficially influences ischaemia-reperfusion injury in mouse lung transplantation.
Jungraithmayr W; De Meester I; Matheeussen V; Baerts L; Arni S; Weder W
Eur J Cardiothorac Surg; 2012 May; 41(5):1166-73. PubMed ID: 22219460
[TBL] [Abstract][Full Text] [Related]
3. Processing by CD26/dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell-derived factor-1alpha.
Proost P; Struyf S; Schols D; Durinx C; Wuyts A; Lenaerts JP; De Clercq E; De Meester I; Van Damme J
FEBS Lett; 1998 Jul; 432(1-2):73-6. PubMed ID: 9710254
[TBL] [Abstract][Full Text] [Related]
4. Cross-talk between the dipeptidyl peptidase-4 and stromal cell-derived factor-1 in stem cell homing and myocardial repair: Potential impact of dipeptidyl peptidase-4 inhibitors.
Anderluh M; Kocic G; Tomovic K; Kocic R; Deljanin-Ilic M; Smelcerovic A
Pharmacol Ther; 2016 Nov; 167():100-107. PubMed ID: 27484974
[TBL] [Abstract][Full Text] [Related]
5. Heparan sulfate/heparin oligosaccharides protect stromal cell-derived factor-1 (SDF-1)/CXCL12 against proteolysis induced by CD26/dipeptidyl peptidase IV.
Sadir R; Imberty A; Baleux F; Lortat-Jacob H
J Biol Chem; 2004 Oct; 279(42):43854-60. PubMed ID: 15292258
[TBL] [Abstract][Full Text] [Related]
6. Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/stromal cell-derived factor-1 alpha-mediated chemotaxis of human cord blood CD34+ progenitor cells.
Christopherson KW; Hangoc G; Broxmeyer HE
J Immunol; 2002 Dec; 169(12):7000-8. PubMed ID: 12471135
[TBL] [Abstract][Full Text] [Related]
7. Truncation of CXCL12 by CD26 reduces its CXC chemokine receptor 4- and atypical chemokine receptor 3-dependent activity on endothelial cells and lymphocytes.
Janssens R; Mortier A; Boff D; Ruytinx P; Gouwy M; Vantilt B; Larsen O; Daugvilaite V; Rosenkilde MM; Parmentier M; Noppen S; Liekens S; Van Damme J; Struyf S; Teixeira MM; Amaral FA; Proost P
Biochem Pharmacol; 2017 May; 132():92-101. PubMed ID: 28322746
[TBL] [Abstract][Full Text] [Related]
8. An angiotensin-converting enzyme inhibitor modulates stromal-derived factor-1 through CD26/dipeptidyl peptidase IV to inhibit laser-induced choroidal neovascularization.
Li H; Wang YS
Mol Vis; 2013; 19():1107-21. PubMed ID: 23734079
[TBL] [Abstract][Full Text] [Related]
9. Skin homing of Sézary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26/dipeptidylpeptidase IV.
Narducci MG; Scala E; Bresin A; Caprini E; Picchio MC; Remotti D; Ragone G; Nasorri F; Frontani M; Arcelli D; Volinia S; Lombardo GA; Baliva G; Napolitano M; Russo G
Blood; 2006 Feb; 107(3):1108-15. PubMed ID: 16204308
[TBL] [Abstract][Full Text] [Related]
10. Dipeptidyl peptidase-IV enzymatic activity bearing molecules in human brain tumors--good or evil?
Busek P; Stremenova J; Sedo A
Front Biosci; 2008 Jan; 13():2319-26. PubMed ID: 17981714
[TBL] [Abstract][Full Text] [Related]
11. Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction.
Zaruba MM; Theiss HD; Vallaster M; Mehl U; Brunner S; David R; Fischer R; Krieg L; Hirsch E; Huber B; Nathan P; Israel L; Imhof A; Herbach N; Assmann G; Wanke R; Mueller-Hoecker J; Steinbeck G; Franz WM
Cell Stem Cell; 2009 Apr; 4(4):313-23. PubMed ID: 19341621
[TBL] [Abstract][Full Text] [Related]
12. Stromal cell-derived factor-1alpha-induced cell proliferation and its possible regulation by CD26/dipeptidyl peptidase IV in endometrial adenocarcinoma.
Mizokami Y; Kajiyama H; Shibata K; Ino K; Kikkawa F; Mizutani S
Int J Cancer; 2004 Jul; 110(5):652-9. PubMed ID: 15146553
[TBL] [Abstract][Full Text] [Related]
13. The effect of DPP-4 inhibition to improve functional outcome after stroke is mediated by the SDF-1α/CXCR4 pathway.
Chiazza F; Tammen H; Pintana H; Lietzau G; Collino M; Nyström T; Klein T; Darsalia V; Patrone C
Cardiovasc Diabetol; 2018 May; 17(1):60. PubMed ID: 29776406
[TBL] [Abstract][Full Text] [Related]
14. Modulation of substance P signaling by dipeptidyl peptidase-IV enzymatic activity in human glioma cell lines.
Busek P; Stremeňová J; Krepela E; Sedo A
Physiol Res; 2008; 57(3):443-449. PubMed ID: 17949241
[TBL] [Abstract][Full Text] [Related]
15. Circulating CD26 is negatively associated with inflammation in human and experimental arthritis.
Busso N; Wagtmann N; Herling C; Chobaz-Péclat V; Bischof-Delaloye A; So A; Grouzmann E
Am J Pathol; 2005 Feb; 166(2):433-42. PubMed ID: 15681827
[TBL] [Abstract][Full Text] [Related]
16. CD26/dipeptidyl peptidase IV regulates prostate cancer metastasis by degrading SDF-1/CXCL12.
Sun YX; Pedersen EA; Shiozawa Y; Havens AM; Jung Y; Wang J; Pienta KJ; Taichman RS
Clin Exp Metastasis; 2008; 25(7):765-76. PubMed ID: 18563594
[TBL] [Abstract][Full Text] [Related]
17. Expression of dipeptidyl peptidase-IV activity and/or structure homologs in human meningiomas.
Stremenová J; Mares V; Lisá V; Hilser M; Krepela E; Vanicková Z; Syrucek M; Soula O; Sedo A
Int J Oncol; 2010 Feb; 36(2):351-8. PubMed ID: 20043068
[TBL] [Abstract][Full Text] [Related]
18. Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1alpha (SDF-1alpha) and SDF-1beta are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage.
Shioda T; Kato H; Ohnishi Y; Tashiro K; Ikegawa M; Nakayama EE; Hu H; Kato A; Sakai Y; Liu H; Honjo T; Nomoto A; Iwamoto A; Morimoto C; Nagai Y
Proc Natl Acad Sci U S A; 1998 May; 95(11):6331-6. PubMed ID: 9600965
[TBL] [Abstract][Full Text] [Related]
19. CD26 inhibition and hematopoiesis: a novel approach to enhance transplantation.
Campbell TB; Broxmeyer HE
Front Biosci; 2008 Jan; 13():1795-805. PubMed ID: 17981668
[TBL] [Abstract][Full Text] [Related]
20. CD26 expression on T cell lines increases SDF-1-alpha-mediated invasion.
Havre PA; Abe M; Urasaki Y; Ohnuma K; Morimoto C; Dang NH
Br J Cancer; 2009 Sep; 101(6):983-91. PubMed ID: 19654580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
